Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Lynn Harris"'
Publikováno v:
Journal of Architectural Environment & Structural Engineering Research. 5:34-51
Lithium ion batteries (LIB) can rupture and result in thermal runaway and battery fires. In the process of transporting lithium ion batteries using trains, the massive collection of batteries can cause train fire and pose significant danger to the pu
Publikováno v:
Journal of Architectural Environment & Structural Engineering Research. 4:9-19
Lithium ion battery fire hazard has been well-documented in a variety of applications. Recently, battery train technology has been introduced as a clean energy concept for railway. In the case of heavy locomotives such as trains, the massive collecti
Publikováno v:
Journal of Environmental Studies and Sciences
Princeville, NC, is the oldest town chartered by Blacks in America. Founded as Freedom Hill in 1865 and incorporated as Princeville in 1885, the town continues to be predominantly African American today. Built on the unwanted and flood-prone lands ad
Autor:
Lynn Harris
Publikováno v:
International Journal of Maritime History. 32:789-807
By the mid-eighteenth century, a distinctive maritime commerce in turtle and manatee products existed in the Caribbean. It was especially prevalent amongst English-speaking inhabitants, from the Cayman Islands and Jamaica to the outposts of Costa Ric
Autor:
Lynn Harris
Publikováno v:
The Palgrave Handbook of Blue Heritage ISBN: 9783030993467
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::465fe31d74bbbe202e02da7f305d467a
https://doi.org/10.1007/978-3-030-99347-4_9
https://doi.org/10.1007/978-3-030-99347-4_9
Autor:
Lynn Harris
Publikováno v:
Antiquity. 95:839-841
Autor:
Windy Lynn Harris
Publikováno v:
The Review Review. 1
Autor:
Nathan Richards, Lynn Harris
Publikováno v:
International Journal of Nautical Archaeology. 47:405-418
Autor:
Lynn Harris, Timothy Calkins
Publikováno v:
Genzyme: The Renvela Launch Decision
Pharmaceutical company Genzyme has created a new drug, Renvela, which is a phosphate binder designed to be used primarily by patients with kidney failure. Renvela is a slightly different version of Genzyme's highly successful Renagel. Company executi